Your browser doesn't support javascript.
loading
A proteome-scale map of the SARS-CoV-2-human contactome.
Kim, Dae-Kyum; Weller, Benjamin; Lin, Chung-Wen; Sheykhkarimli, Dayag; Knapp, Jennifer J; Dugied, Guillaume; Zanzoni, Andreas; Pons, Carles; Tofaute, Marie J; Maseko, Sibusiso B; Spirohn, Kerstin; Laval, Florent; Lambourne, Luke; Kishore, Nishka; Rayhan, Ashyad; Sauer, Mayra; Young, Veronika; Halder, Hridi; la Rosa, Nora Marín-de; Pogoutse, Oxana; Strobel, Alexandra; Schwehn, Patrick; Li, Roujia; Rothballer, Simin T; Altmann, Melina; Cassonnet, Patricia; Coté, Atina G; Vergara, Lena Elorduy; Hazelwood, Isaiah; Liu, Betty B; Nguyen, Maria; Pandiarajan, Ramakrishnan; Dohai, Bushra; Coloma, Patricia A Rodriguez; Poirson, Juline; Giuliana, Paolo; Willems, Luc; Taipale, Mikko; Jacob, Yves; Hao, Tong; Hill, David E; Brun, Christine; Twizere, Jean-Claude; Krappmann, Daniel; Heinig, Matthias; Falter, Claudia; Aloy, Patrick; Demeret, Caroline; Vidal, Marc; Calderwood, Michael A.
Afiliación
  • Kim DK; Donnelly Centre for Cellular and Biomolecular Research (CCBR), University of Toronto, Toronto, Ontario, Canada.
  • Weller B; Department of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada.
  • Lin CW; Lunenfeld-Tanenbaum Research Institute (LTRI), Sinai Health System, Toronto, Ontario, Canada.
  • Sheykhkarimli D; Center for Cancer Systems Biology (CCSB), Dana-Farber Cancer Institute, Boston, MA, USA.
  • Knapp JJ; Department of Cancer Genetics and Genomics, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.
  • Dugied G; Institute of Network Biology (INET), Molecular Targets and Therapeutics Center (MTTC), Helmholtz Zentrum München, German Research Center for Environmental Health, Munich-Neuherberg, Germany.
  • Zanzoni A; Institute of Network Biology (INET), Molecular Targets and Therapeutics Center (MTTC), Helmholtz Zentrum München, German Research Center for Environmental Health, Munich-Neuherberg, Germany.
  • Pons C; Donnelly Centre for Cellular and Biomolecular Research (CCBR), University of Toronto, Toronto, Ontario, Canada.
  • Tofaute MJ; Department of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada.
  • Maseko SB; Lunenfeld-Tanenbaum Research Institute (LTRI), Sinai Health System, Toronto, Ontario, Canada.
  • Spirohn K; Center for Cancer Systems Biology (CCSB), Dana-Farber Cancer Institute, Boston, MA, USA.
  • Laval F; Donnelly Centre for Cellular and Biomolecular Research (CCBR), University of Toronto, Toronto, Ontario, Canada.
  • Lambourne L; Department of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada.
  • Kishore N; Lunenfeld-Tanenbaum Research Institute (LTRI), Sinai Health System, Toronto, Ontario, Canada.
  • Rayhan A; Center for Cancer Systems Biology (CCSB), Dana-Farber Cancer Institute, Boston, MA, USA.
  • Sauer M; Unité de Génétique Moléculaire des Virus à ARN, Département de Virologie, Institut Pasteur, Paris, France.
  • Young V; UMR3569, Centre National de la Recherche Scientifique, Paris, France.
  • Halder H; Université de Paris, Paris, France.
  • la Rosa NM; Aix-Marseille Université, Inserm, TAGC, Marseille, France.
  • Pogoutse O; Institute for Research in Biomedicine (IRB Barcelona), Barcelona Institute for Science and Technology, Barcelona, Spain.
  • Strobel A; Research Unit Cellular Signal Integration, Institute of Molecular Toxicology and Pharmacology, Molecular Targets and Therapeutics Center (MTTC), Helmholtz Zentrum München, German Research Center for Environmental Health, Munich-Neuherberg, Germany.
  • Schwehn P; Laboratory of Viral Interactomes, GIGA Institute, University of Liège, Liège, Belgium.
  • Li R; Center for Cancer Systems Biology (CCSB), Dana-Farber Cancer Institute, Boston, MA, USA.
  • Rothballer ST; Department of Genetics, Blavatnik Institute, Harvard Medical School, Boston, MA, USA.
  • Altmann M; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Cassonnet P; Center for Cancer Systems Biology (CCSB), Dana-Farber Cancer Institute, Boston, MA, USA.
  • Coté AG; Laboratory of Viral Interactomes, GIGA Institute, University of Liège, Liège, Belgium.
  • Vergara LE; Department of Genetics, Blavatnik Institute, Harvard Medical School, Boston, MA, USA.
  • Hazelwood I; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Liu BB; TERRA Teaching and Research Centre, University of Liège, Gembloux, Belgium.
  • Nguyen M; Laboratory of Molecular and Cellular Epigenetics, GIGA Institute, University of Liège, Liège, Belgium.
  • Pandiarajan R; Center for Cancer Systems Biology (CCSB), Dana-Farber Cancer Institute, Boston, MA, USA.
  • Dohai B; Department of Genetics, Blavatnik Institute, Harvard Medical School, Boston, MA, USA.
  • Coloma PAR; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Poirson J; Donnelly Centre for Cellular and Biomolecular Research (CCBR), University of Toronto, Toronto, Ontario, Canada.
  • Giuliana P; Department of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada.
  • Willems L; Lunenfeld-Tanenbaum Research Institute (LTRI), Sinai Health System, Toronto, Ontario, Canada.
  • Taipale M; Center for Cancer Systems Biology (CCSB), Dana-Farber Cancer Institute, Boston, MA, USA.
  • Jacob Y; Donnelly Centre for Cellular and Biomolecular Research (CCBR), University of Toronto, Toronto, Ontario, Canada.
  • Hao T; Department of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada.
  • Hill DE; Lunenfeld-Tanenbaum Research Institute (LTRI), Sinai Health System, Toronto, Ontario, Canada.
  • Brun C; Center for Cancer Systems Biology (CCSB), Dana-Farber Cancer Institute, Boston, MA, USA.
  • Twizere JC; Institute of Network Biology (INET), Molecular Targets and Therapeutics Center (MTTC), Helmholtz Zentrum München, German Research Center for Environmental Health, Munich-Neuherberg, Germany.
  • Krappmann D; Institute of Network Biology (INET), Molecular Targets and Therapeutics Center (MTTC), Helmholtz Zentrum München, German Research Center for Environmental Health, Munich-Neuherberg, Germany.
  • Heinig M; Institute of Network Biology (INET), Molecular Targets and Therapeutics Center (MTTC), Helmholtz Zentrum München, German Research Center for Environmental Health, Munich-Neuherberg, Germany.
  • Falter C; Institute of Network Biology (INET), Molecular Targets and Therapeutics Center (MTTC), Helmholtz Zentrum München, German Research Center for Environmental Health, Munich-Neuherberg, Germany.
  • Aloy P; Donnelly Centre for Cellular and Biomolecular Research (CCBR), University of Toronto, Toronto, Ontario, Canada.
  • Demeret C; Department of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada.
  • Vidal M; Lunenfeld-Tanenbaum Research Institute (LTRI), Sinai Health System, Toronto, Ontario, Canada.
  • Calderwood MA; Center for Cancer Systems Biology (CCSB), Dana-Farber Cancer Institute, Boston, MA, USA.
Nat Biotechnol ; 41(1): 140-149, 2023 01.
Article en En | MEDLINE | ID: mdl-36217029
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: SARS-CoV-2 / COVID-19 Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: SARS-CoV-2 / COVID-19 Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Año: 2023 Tipo del documento: Article